Decreased T-bet expression and changes in chemokine levels in adults with asthma

Clinical and Experimental Immunology

Volumn 147, Issue 3, 2007, Pages 526-532

  Ko, F W S ^a,b   Lun, S W M ^a   Wong, C K ^a   Szeto, C C ^a   Lam, C W K ^a   Leung, T F ^a   Hui, D S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asthma; Chemokines; Peripheral blood; T bet expression

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ACTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; CORTICOSTEROID; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN E; INTERLEUKIN 8; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SALBUTAMOL; STEROID; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ADULT; ASTHMA; CASE-CONTROL STUDIES; CHEMOKINES; CHEMOKINES, CXC; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-BOX DOMAIN PROTEINS;

EID: 33846839274     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03315.x     Document Type: Article

References (38)

1. National Heart, Blood and Lung, World Heath Organisation. Global Strategy for asthma management and prevention. Maryland: National Institutes of Health. NIH Publication no. 02-3659, 2005 update. 2005.
2. Romagnani S. T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol 2001; 1:73-8.
3. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100:655-69.
4. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295:338-42.
5. Yin Z, Chen C, Szabo SJ, Glimcher LH, Ray A, Craft J. T-bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J Immunol 2002; 168:1566-71.
6. Finotto S, Neurath MF, Glickman JN et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295:336-8.
7. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21.
8. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7.
9. Smit JJ, Lukacs NW. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 2006; 533:277-88.
10. Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulmon Med 2005; 11:35-42.
11. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101:746-54.
12. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995; 182:1301-14.
13. Rojas-Ramos E, Avalos AF, Perez-Fernandez L, Cuevas-Schacht F, Valencia-Maqueda E, Teran LM. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. Eur Respir J 2003; 22:310-16.
14. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997; 156:1377-83.
15. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329-36.
16. Lun SW, Wong CK, Ko FW, Ip WK, Hui DS, Lam CW. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. J Clin Immunol 2006; 26:145-52.
17. Robinson DS, Lloyd CM. Asthma: T-bet - a master controller? Curr Biol 2002; 12:R322-4.
18. Schwartz RS. A new element in the mechanism of asthma. N Engl J Med 2002; 346:857-8.
19. Lord GM, Rao RM, Choe H et al. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005; 106:3432-9.
20. British Thoracic Society. Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. Thorax 2003; 58 (Suppl. 1):1-94.
21. American Thoracic Society. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1285-98.
22. Ip MS, Ko FW, Lau AC et al. Updated spirometric reference values for adult chinese in Hong Kong and implications on clinical utilization. Chest 2006; 129:384-92.
23. Lighvani AA, Frucht DM, Jankovic D et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA 2001; 98:15137-42.
24. Lam CW, Fung HK, Vrijmoed LL. Aetiology of allergic rhinitis in Hong Kong. Allergol Int 1998; 47:23-8.
25. Leung R, Ho P, Lam CW, Lai CK. Sensitization to inhaled allergens as a risk factor for asthma and allergic diseases in Chinese population. J Allergy Clin Immunol 1997; 99:594-9.
26. Chan RW, Lai FM, Li EK et al. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant 2006; 21:1534-40.
27. Tantisira KG, Hwang ES, Raby BA et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci USA 2004; 101:18099-104.
28. Raby BA, Hwang ES, Van Steen K et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med 2006; 173:64-70.
29. Hohler T, Reuss E, Adams P et al. A genetic basis for IFN-gamma production and T-bet expression in humans. J Immunol 2005; 175:5457-62.
30. Ritz SA, Cundall MJ, Gajewska BU et al. The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratorymucosal sensitization to antigen in vivo. Clin Exp Immunol 2004; 138:213-20.
31. Fukakusa M, Bergeron C, Tulic MK et al. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 2005; 115:280-6.
32. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of thememory phenotype by cytokine RANTES. Nature 1990; 347:669-71.
33. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587-92.
34. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997; 158:4398-404.
35. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176:1489-95.
36. Romagnoli M, Vachier I, Tarodo de la Fuente P et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002; 20:1370-7.
37. Di Gioacchino M, Verna N, Cavallucci E et al. Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patients. Int J Immunopathol Pharmacol 2002; 15:27-34.
38. Oomizu S, Onishi N, Suzuki H et al. Oral administration of pulverized Konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. Clin Exp Allergy 2006; 36:102-10.